The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 31, 2017
Filed:
Nov. 19, 2010
Applicants:
Jean-sebastien Garrigue, Verrieres-le-Buisson, FR;
Frederic Lallemand, Fresnes, FR;
Philippe Daull, Soisy-sur-Seine, FR;
Christophe Baudouin, Paris, FR;
Inventors:
Jean-Sebastien Garrigue, Verrieres-le-Buisson, FR;
Frederic Lallemand, Fresnes, FR;
Philippe Daull, Soisy-sur-Seine, FR;
Christophe Baudouin, Paris, FR;
Assignee:
SANTEN SAS, Evry, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/216 (2006.01); A61K 31/5575 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2006.01); A61K 47/18 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5575 (2013.01); A61K 9/0048 (2013.01); A61K 9/107 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 31/216 (2013.01);
Abstract
A composition for use in treating corneal and conjunctival lesions, includes a prostaglandin F2alpha or analogue, in a therapeutic amount, the composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative. A method for treating surface ocular conditions in a patient in need thereof, includes administering an effective amount of the composition.